Rock Springs Capital Management LP Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Rock Springs Capital Management LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Rock Springs Capital Management LP. Rock Springs Capital Management LP is in Cerulean Pharma Inc. ($CERU) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Homology Medicines, Inc. ($FIXX) and 10% Owner in IMARA Inc. ($IMRA) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in Verve Therapeutics, Inc. ($VERV).
Latest Insider Trading Transactions of Rock Springs Capital Management LP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, DARE, FIXX, IMRA, INZY, VERV
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2021 | VERV | Verve Therapeutics ... | Rock Springs Capital Managemen ... | 10% Owner | Option Exercise | C | 0.00 | 1,416,023 | 0 | 0 | |
Jun 22 2021 | VERV | Verve Therapeutics ... | Rock Springs Capital Managemen ... | 10% Owner | Option Exercise | C | 0.00 | 5,151,043 | 0 | 0 | |
Jun 22 2021 | VERV | Verve Therapeutics ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | C | 0.00 | 152,926 | 0 | 152,926 | 0 to 152.9 K |
Jun 22 2021 | VERV | Verve Therapeutics ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | P | 19.00 | 370,000 | 7,030,000 | 926,298 | 556.3 K to 926.3 K (+66.51 %) |
Jun 22 2021 | VERV | Verve Therapeutics ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | C | 0.00 | 556,298 | 0 | 556,298 | 0 to 556.3 K |
Jul 28 2020 | INZY | Inozyme Pharma, In ... | Rock Springs Capital Managemen ... | 10% Owner | Option Exercise | C | 0.00 | 3,496,504 | 0 | 0 | |
Jul 28 2020 | INZY | Inozyme Pharma, In ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | P | 16.00 | 24,000 | 384,000 | 1,067,884 | 1 M to 1.1 M (+2.30 %) |
Jul 28 2020 | INZY | Inozyme Pharma, In ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | P | 16.00 | 576,000 | 9,216,000 | 1,043,884 | 467.9 K to 1 M (+123.11 %) |
Jul 28 2020 | INZY | Inozyme Pharma, In ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | C | 0.00 | 467,884 | 0 | 467,884 | 0 to 467.9 K |
Jul 28 2020 | INZY | Inozyme Pharma, In ... | Rock Springs Capital Managemen ... | 10% Owner | Option Exercise | C | 0.00 | 3,496,504 | 0 | 0 | |
Jul 28 2020 | INZY | Inozyme Pharma, In ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | P | 16.00 | 24,000 | 384,000 | 1,067,884 | 1 M to 1.1 M (+2.30 %) |
Jul 28 2020 | INZY | Inozyme Pharma, In ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | P | 16.00 | 576,000 | 9,216,000 | 1,043,884 | 467.9 K to 1 M (+123.11 %) |
Jul 28 2020 | INZY | Inozyme Pharma, In ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | C | 0.00 | 467,884 | 0 | 467,884 | 0 to 467.9 K |
Mar 16 2020 | IMRA | IMARA Inc. | Rock Springs Capital Managemen ... | 10% Owner | Option Exercise | C | 0.00 | 1,722,222 | 0 | 0 | |
Mar 16 2020 | IMRA | IMARA Inc. | Rock Springs Capital Managemen ... | 10% Owner | Buy | P | 16.00 | 250,000 | 4,000,000 | 523,411 | 273.4 K to 523.4 K (+91.44 %) |
Mar 16 2020 | IMRA | IMARA Inc. | Rock Springs Capital Managemen ... | 10% Owner | Buy | C | 0.00 | 273,411 | 0 | 273,411 | 0 to 273.4 K |
Apr 04 2018 | FIXX | Homology Medicines ... | Rock Springs Capital Managemen ... | 10% Owner | Option Exercise | C | 0.00 | 395,845 | 0 | 0 | |
Apr 04 2018 | FIXX | Homology Medicines ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | P | 16.00 | 250,000 | 4,000,000 | 645,845 | 395.8 K to 645.8 K (+63.16 %) |
Apr 04 2018 | FIXX | Homology Medicines ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | C | 0.00 | 395,845 | 0 | 395,845 | 0 to 395.8 K |
Jun 24 2015 | NVLS | Nivalis Therapeuti ... | Rock Springs Capital Managemen ... | 10% Owner | Option Exercise | C | 2.85 | 364,358 | 1,038,420 | 0 | |
Jun 24 2015 | NVLS | Nivalis Therapeuti ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | P | 14.00 | 200,000 | 2,800,000 | 564,358 | 364.4 K to 564.4 K (+54.89 %) |
Jun 24 2015 | NVLS | Nivalis Therapeuti ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | C | 0.00 | 364,358 | 0 | 364,358 | 0 to 364.4 K |
Apr 15 2014 | CERU | Cerulean Pharma In ... | Rock Springs Capital Managemen ... | Buy | C | 0.00 | 464,365 | 0 | 464,365 | 0 to 464.4 K |
Page: 1